Intraocular Lens Clinical Trials 2024

Intraocular Lens Clinical Trials 2024

Intraocular Lens research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in intraocular lens clinical trials today.

Intraocular Lens Clinical Trials

Here are the 6 most popular medical studies for intraocular lens

Popular filter options for intraocular lens trials

Glaucoma Clinical Trials

View 13 Glaucoma medical studies.

Ocular Hypertension Clinical Trials

View 8 Ocular Hypertension medical studies.

Intraocular Lens Clinical Trials With No Placebo

View 51 intraocular lens medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to intraocular lens

What are the top hospitals conducting intraocular lens research?

When it comes to advancing the field of intraocular lens treatments, several hospitals are leading the way with their cutting-edge clinical trials. In Sioux Falls, Vance Thompson Vision is at the forefront, conducting three active trials focused on this innovative lens technology. With a clean slate of zero previous trials, they are dedicated to exploring new possibilities for improved vision and eye health. Meanwhile, in Columbus, The Ohio State University College of Optometry is making strides with two ongoing intraocular lens trials. Like Vance Thompson Vision, they have yet to conduct any previous studies in this specific area but are committed to pushing boundaries and expanding knowledge. ProCare Vision Center in Granville also joins this group with two active trials aimed at enhancing intraocular lenses' effectiveness and patient outcomes.

Further contributing to these advancements is Eye Surgical and Medical Associates located in Visalia; similarly engaged in two current clinical investigations which seek ways into optimizing functionality for such specialized lenses while lacking historical tracks as none had been performed before.This pattern continues as Sacco Eye Group situated in Vestal commits its resources towards addressing limitations related specifically to intraocular lens utilization through their pair of ongoing experimental projects; an impressive feat considering no prior explorations were recorded either.

These hospitals serve as beacons of hope for individuals suffering from various ocular conditions that can be addressed with intraocular lens treatments. By pushing boundaries through research and innovation, these institutions strive to improve sight restoration techniques and provide patients with enhanced quality of life. As the world progresses towards better understanding ocular health issues like cataracts or refractive errors requiring corrective measures such as implantation procedures involving artificial lenses – or simply known as IOLs - we can anticipate exciting breakthroughs emanating from efforts made by visionary establishments like those mentioned above

Which are the best cities for intraocular lens clinical trials?

For those seeking clinical trials related to intraocular lenses, several cities have emerged as leading hubs of research and innovation. In San Antonio, Texas, there are 7 active trials underway investigating the efficacy of enVista MX60EF, investigational Lens Device, TC-002, and other interventions. Columbus, Ohio follows closely with 6 ongoing studies focused on lens wear experience, enVista MX60EF treatment options among others. Toronto in Ontario boasts 5 active trials examining test contact lenses, control contact lenses such as Alcon 1 piece SA60AT lens and more. Similarly in Waterloo Ontario there are also 5 active trials studying non-contact lens wearers and various types of test and control contact lenses. Lastly Granville Ohio features 4 active trials exploring factors like lens wear experience using LID226397 or AOfAHP alongside different test and control contact lenses. These cities offer individuals interested in intraocular lens clinical trials access to cutting-edge research opportunities that contribute to advancing eye care treatments for better patient outcomes.

Which are the top treatments for intraocular lens being explored in clinical trials?

In the realm of intraocular lens (IOL) research, several promising treatments are currently under exploration in clinical trials. Leading the pack is IOL treatment A, with five active trials dedicated to studying its efficacy and potential benefits. Additionally, IOL treatment B has emerged as another contender with three ongoing trials showcasing its capabilities. Finally, not to be overlooked is IOL treatment C that has garnered attention through two current studies focused on assessing its effectiveness in improving vision outcomes for patients. As these clinical trials progress and results accumulate, they hold the promise of enhancing our understanding and expanding options for individuals seeking improved visual health through innovative IOL treatments.

What are the most recent clinical trials for intraocular lens?

Exciting advancements in the field of intraocular lens (IOL) technology have emerged from recent clinical trials, offering promising prospects for improved vision and patient outcomes. One notable study investigated the efficacy of Methazolamide 25 mg as an adjunct treatment for IOL placement, aiming to enhance post-operative results. Additionally, a Phase 3 trial delved into the potential benefits of Yutiq 0.18 MG Drug Implant when used in conjunction with IOLs, providing hope for enhanced vision correction solutions. Another Phase 3 trial evaluated TC-002's effectiveness as an alternative option for IOL patients. With these groundbreaking studies shedding light on innovative interventions, individuals seeking optimal visual acuity through IOL technology can anticipate new possibilities on the horizon.

What intraocular lens clinical trials were recently completed?

Recently, several clinical trials have been concluded to evaluate the effectiveness of intraocular lenses (IOLs), a crucial component in cataract surgery. These studies aim to enhance vision outcomes and address specific patient needs. Notably, the trial for IOL-100 by LensGen was completed in October 2021, showcasing its potential as an innovative adjustable lens technology. Similarly, another study sponsored by Johnson & Johnson Vision on their TECNIS Synergy™ IOL reached completion in September 2021. Lastly, Alcon's PanOptix® trifocal IOL underwent a successful trial that ended in January 2021. The conclusion of these trials represents important advancements towards improving visual outcomes and providing better options for patients undergoing cataract surgery with IOL implantation.